FUSI FABIO

Office hours

  • Monday from 11:00 to 13:00
    Place: Studio del docente - Polo Scientifico Universitario di San Miniato
    Note: Previo appuntamento
The Professor receives by appointment by email.

Contacts

0577235377 [int.5377] (Lab Patch 1),0577235203 [int.5203] (Ufficio),0577232375 [int.2375] (Lab Patch 2)

Curriculum Vitae

Teaching activities

Completion accademic year: 2025/2026

Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023

Completion accademic year: 2024/2025

Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2021/2022
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2021/2022
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2021/2022

Completion accademic year: 2023/2024

Research

Ultime pubblicazioni:

  • Gentile, M., Panti, A., Paccagnini, E., Lupetti, P., Bova, S., Fusi, F. (2025). Ba2+-Induced Vasoconstriction as a Model to Investigate the Dynamin Dependence of Biological Processes Regulating Vascular Tone. PHARMACOLOGY RESEARCH & PERSPECTIVES, 13(6) [10.1002/prp2.70184]. - view more
  • Fusi, F., Saponara, S., Carullo, G., Panti, A., Bichicchi, A., Pifferi, A., et al. (2025). The insulin-releasing agent quercetin-3-oleate stimulates CaV1.2 channels similarly to quercetin, though with a reduced vasorelaxant activity. EUROPEAN JOURNAL OF PHARMACOLOGY, 1003 [10.1016/j.ejphar.2025.177902]. - view more
  • Medana, C., Spizzirri, U.G., Schiavo, V., Fusi, F., Panti, A., Saponara, S., et al. (2024). Screening of the antioxidant and vasorelaxant activity of wine waste ultrasonic extracts, and HRMS targeted and semi-targeted profiling of glycosylated polyphenols vs free polyphenols. LEBENSMITTEL-WISSENSCHAFT + TECHNOLOGIE, 208 [10.1016/j.lwt.2024.116666]. - view more
  • Fusi, F., Saponara, S., Brimble, M.A., Rennison, D., Hopkins, B., Bova, S. (2024). The Enigma of Norbormide, a Rattus-Selective Toxicant. CELLS, 13(9) [10.3390/cells13090788]. - view more
  • Ibba, R., Sestito, S., Ambrosio, F.A., Marchese, E., Costa, G., Fiorentino, F.P., et al. (2024). Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 276 [10.1016/j.ejmech.2024.116647]. - view more